ACCD Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Accolade Inc - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 9.18 USD 0.11%

Updated:

Section:

Wall Street
Price Targets

Wall Street analysts forecast ACCD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACCD is 15.37 USD with a low forecast of 12.12 USD and a high forecast of 18.9 USD.

ACCD Lowest Forecast

Wall Street Target

ACCD Average Forecast

Wall Street Target

ACCD Highest Forecast

Wall Street Target

32% Upside

67% Upside

106% Upside

The latest public price target was made on Oct 4, 2023 by Ricky Goldwasser from Morgan Stanley , who expects ACCD stock to rise by 53% over the next 12 months. You can read more about this price target by viewing the article on Benzinga.

Analyst	Price Target	Date	Article
Ricky Goldwasser Morgan Stanley	14 USD Upside 53%	6 months ago Oct 4, 2023	Accolade Gears Up For Q2 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Benzinga
Ryan MacDonald Needham	14.27 USD Upside 55%	9 months ago Jun 30, 2023	NVIDIA To Rally Over 16%? Here Are 10 Other Analyst Forecasts For Friday Benzinga

Price Target	14 USD
Upside/Downside	53%

Price Target	14.27 USD
Upside/Downside	55%

Cross Country Healthcare Inc

13% Upside

Cryo-Cell International Inc

11% Upside

dentalcorp Holdings Ltd

58% Upside

Gushengtang Holdings Ltd

59% Upside

Cross Country Healthcare Inc

13% Upside

Cryo-Cell International Inc

11% Upside

dentalcorp Holdings Ltd

58% Upside

Gushengtang Holdings Ltd

59% Upside

BML Inc

9% Upside

Adicon Holdings Ltd

46% Upside

DaVita Inc

5% Upside

Fulgent Genetics Inc

35% Upside

Revenue
Forecast

For the last 4 years the compound annual growth rate for Accolade Inc's revenue is 40%. The projected CAGR for the next 4 years is 19%.

40%

19%

N/A

N/A

What are analyst estimates?

Operating Income
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

Net Income
Forecast

N/A

N/A

N/A

N/A

What are analyst estimates?

See Also

Relative Valuation

Wall Street Estimates

Profitability Analysis

Solvency Analysis

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

According to Wall Street analysts, the average 1-year price target for ACCD is 15.37 USD with a low forecast of 12.12 USD and a high forecast of 18.9 USD.

For the last 4 years the compound annual growth rate for Accolade Inc's revenue is 40%. The projected CAGR for the next 4 years is 19%.

Join more than 129,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.